Skip to main content

So Much for That Biotech ETF Bubble

It seems like only yesterday that there was a cacophony of criticism and doubt from naysayers regarding biotechnology stock and exchange traded funds. In reality, “yesterday” was the first quarter when the usually pricey biotech sector soared to valuations that were double its already high...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.